Piedmont Capital Partners

Summary

The company was established in North America in United States. The main department of described Corporate Investor is located in the Greensboro.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Piedmont Capital Partners, startups are often financed by Solas BioVentures, Pfizer Venture Investments, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Barer & Son Capital, XSeed Capital, William A. Hawkins III. In the next rounds fund is usually obtained by Silver Lake Kraftwerk, Sequoia Capital, GV.

The common things for fund are deals in the range of 5 - 10 millions dollars. The real fund results show that this Corporate Investor is 0 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2018.

Among the various public portfolio startups of the fund, we may underline Carbon3D, AsclepiX Therapeutics, CardioNXT The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Biopharma.